Original language | English |
---|---|
Pages (from-to) | 703-704 |
Number of pages | 2 |
Journal | Nature Methods |
Volume | 11 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2014 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Nature Methods, Vol. 11, No. 7, 07.2014, p. 703-704.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - CPTAC Assay Portal
T2 - A repository of targeted proteomic assays
AU - Whiteaker, Jeffrey R.
AU - Halusa, Goran N.
AU - Hoofnagle, Andrew N.
AU - Sharma, Vagisha
AU - MacLean, Brendan
AU - Yan, Ping
AU - Wrobel, John A.
AU - Kennedy, Jacob
AU - Mani, D. R.
AU - Zimmerman, Lisa J.
AU - Meyer, Matthew R.
AU - Mesri, Mehdi
AU - Rodriguez, Henry
AU - Paulovich, Amanda G.
AU - Abbatiello, Susan E.
AU - Boja, Emily
AU - Carr, Steven A.
AU - Chan, Daniel W.
AU - Chen, Xian
AU - Chen, Jing
AU - Davies, Sherri R.
AU - Ellis, Matthew J.C.
AU - Fenyö, David
AU - Hiltke, Tara
AU - Ketchum, Karen A.
AU - Kinsinger, Chris
AU - Kuhn, Eric
AU - Liebler, Daniel C.
AU - Lin, De
AU - Liu, Tao
AU - Loss, Michael
AU - MacCoss, Michael J.
AU - Qian, Wei Jun
AU - Rivers, Robert
AU - Rodland, Karin D.
AU - Ruggles, Kelly V.
AU - Scott, Mitchell G.
AU - Smith, Richard D.
AU - Thomas, Stefani
AU - Townsend, R. Reid
AU - Whiteley, Gordon
AU - Wu, Chaochao
AU - Zhang, Hui
AU - Zhang, Zhen
N1 - Funding Information: This work was funded by the Clinical Proteomic Tumor Analysis Consortium (CPTAC) of the US National Cancer Institute under grant nos. U24CA160034 (S.A.C., A.G.P.), U24CA160036 (D.W.C.), U24CA160019 (R.D.S., K.D.R.), U24CA159988 (D.C.L.) and U24CA160035 (M.J.C.E.), as well as US National Institutes of Health grant nos. R01GM103551 (M.J.M.) and U01CA164186 (M.J.M.). Funding Information: Data quality is a key emphasis and distinguishing feature of the portal. A framework for MRM assay ‘fit-for-purpose’ validation has been established by CPTAC, with input from the outside community solicited via a workshop jointly sponsored by the NCI and the National Heart, Lung, and Blood Institute4. Assays presented on the portal predominantly represent ‘Tier 2’ assays, as described in the workshop report. To ensure sufficient assay characterization and data quality, a guidance document describing the minimal characterization data required for assay inclusion in the CPTAC Assay Portal is available for download (https://assays.cancer.gov/guidance-document/). This guidance document outlines a list of characterizations that will help potential downstream users evaluate the utility of adopting and deploying the assays in their own work. Five experiments are outlined (Fig. 1b); experiments 1 and 2 are required for upload. Assays are entered through a web-based entry form and the uploading of data to Panorama. Characterization experiments are analyzed by scripts available through Panorama. Uploaded assays are subjected to manual review by site administrators to ensure data quality and the fulfillment of minimum requirements for assay characterization.
PY - 2014/7
Y1 - 2014/7
UR - http://www.scopus.com/inward/record.url?scp=84903542932&partnerID=8YFLogxK
U2 - 10.1038/nmeth.3002
DO - 10.1038/nmeth.3002
M3 - Letter
C2 - 24972168
AN - SCOPUS:84903542932
SN - 1548-7091
VL - 11
SP - 703
EP - 704
JO - Nature Methods
JF - Nature Methods
IS - 7
ER -